This local anti-PD-L1 antibody delivery led to a five-fold reduction in tumor growth and a 50–80% reduction in tumor weight when compared with anti-CAIX CAR-T cells alone in a humanized mice model of clear cell renal cell carcinoma. This evidence concerns the gene CA9 and neoplasm.